Gary Hewett
Non-Executive Director
Ellume
Australia
Biography
Gary Hewett has developed and commercialised in the US five novel diagnostic products over the course of his career. The first of these, Cholestech LDX, remains widely used nearly 30 years after development. Gary has been part of executive management in three NASDAQ listed companies and has successfully exited companies through trade-sale. Gary is based in the Bay Area of California and has a BSc in Neurobiology from University of California Berkley.
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management
